1. Home
  2. TRDA vs RGCO Comparison

TRDA vs RGCO Comparison

Compare TRDA & RGCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRDA
  • RGCO
  • Stock Information
  • Founded
  • TRDA 2016
  • RGCO 1912
  • Country
  • TRDA United States
  • RGCO United States
  • Employees
  • TRDA N/A
  • RGCO N/A
  • Industry
  • TRDA Biotechnology: Pharmaceutical Preparations
  • RGCO Oil & Gas Production
  • Sector
  • TRDA Health Care
  • RGCO Utilities
  • Exchange
  • TRDA Nasdaq
  • RGCO Nasdaq
  • Market Cap
  • TRDA 220.1M
  • RGCO 221.2M
  • IPO Year
  • TRDA 2021
  • RGCO N/A
  • Fundamental
  • Price
  • TRDA $5.62
  • RGCO $21.37
  • Analyst Decision
  • TRDA Strong Buy
  • RGCO
  • Analyst Count
  • TRDA 3
  • RGCO 0
  • Target Price
  • TRDA $25.67
  • RGCO N/A
  • AVG Volume (30 Days)
  • TRDA 260.6K
  • RGCO 19.0K
  • Earning Date
  • TRDA 08-06-2025
  • RGCO 08-11-2025
  • Dividend Yield
  • TRDA N/A
  • RGCO 3.95%
  • EPS Growth
  • TRDA N/A
  • RGCO 5.90
  • EPS
  • TRDA N/A
  • RGCO 1.32
  • Revenue
  • TRDA $79,476,000.00
  • RGCO $94,120,500.00
  • Revenue This Year
  • TRDA N/A
  • RGCO $10.87
  • Revenue Next Year
  • TRDA N/A
  • RGCO $3.26
  • P/E Ratio
  • TRDA N/A
  • RGCO $15.85
  • Revenue Growth
  • TRDA N/A
  • RGCO 12.04
  • 52 Week Low
  • TRDA $4.93
  • RGCO $19.06
  • 52 Week High
  • TRDA $21.79
  • RGCO $24.20
  • Technical
  • Relative Strength Index (RSI)
  • TRDA 43.81
  • RGCO 49.57
  • Support Level
  • TRDA $5.09
  • RGCO $20.62
  • Resistance Level
  • TRDA $5.47
  • RGCO $23.01
  • Average True Range (ATR)
  • TRDA 0.41
  • RGCO 0.75
  • MACD
  • TRDA 0.04
  • RGCO 0.05
  • Stochastic Oscillator
  • TRDA 41.82
  • RGCO 50.75

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.

About RGCO RGC Resources Inc.

RGC Resources Inc is involved in the business of distribution and sale of natural gas to residential, commercial, and industrial customers within its service territory in Roanoke, Virginia, and its surrounding localities. The company also provides certain non-regulated services. The company relies on multiple interstate pipelines to transport natural gas. The company operates in three segments: Gas Utility, which is the key revenue generator; Investment in Affiliates this segment reflects the income generated through the activities of the Company's investment in MVP and Southgate projects and Parent & Other including the unregulated activities of the Company as well as certain corporate eliminations.

Share on Social Networks: